Long-acting flunixin meglumine injection and method for preparing same

A technology for flunixin meglumine and injection, which is applied in the field of long-acting flunixin meglumine injection and its preparation, can solve the problems of short half-life, fast excretion, unfavorable treatment of animal diseases, etc., and reduce labor intensity , Improve the effect of treatment, reduce the effect of stress response

Active Publication Date: 2010-11-10
SHAOSHAN DABEINONG ANIMAL MEDICINE +1
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Flunixin meglumine absorbs quickly, but excretes quickly and has a short half-life, requiring multiple administrations to achieve the desired therapeutic effect, which not only consumes a lot of manpower but also causes multiple stresses to sick animals, which is not conducive to The treatment of the disease does not meet the requirements of animal welfare

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Long-acting flunixin meglumine injection and method for preparing same

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

Embodiment 2

Embodiment 3

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention relates to a long-acting flunixin meglumine injection for animals and method for preparing same. The invention provided flunixin meglumine injection delays medicine absorption soas to prolong medicine action time by adding proper polyvinylpyrrolidone and poloxamer high molecular compound in the preparation process. Approved by clinical experiments that action time of the invention is longer than common flunixin meglumine injection, the invention reduces labor strength and reduces stress response of animals with more obvious medicine effect, and capable of using with long-acting antibacterials to provide a synergistic effect. The invention provides a animals specific medicine of long-acting, effective antipyretic, antiphlogosis and analgesic for veterinary clinical.

Description

A kind of long-acting flunixin meglumine injection and preparation method thereof technical field The invention belongs to the technical field of veterinary preparations, and relates to a long-acting flunixin meglumine injection and a preparation method thereof. Background technique Schering-Plough Corporation of the United States launched a non-steroidal drug for animals - flunixin meglumine (flunixin meglumine) at the end of the last century. It has a unique structure and is a cyclooxygenase inhibitor. It inhibits the prostate by interacting with prostaglandin synthase. The production of toxin can effectively prevent the increase of bronchial exudate caused by E. coli endotoxin in respiratory diseases, and the accumulation of neutrophils and albumin in the exudate. It is a very effective anti-inflammatory and analgesic , non-steroidal anti-inflammatory drugs with anti-endotoxin and antipyretic effects. Because livestock and poultry are attacked by bacteria, viruses, an...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/08A61K31/44A61K47/34A61K47/32A61P29/00A61K47/10
Inventor 田玲杨秀玉周德刚秦玉明莫云刘澜冯华兵葛代兴葛冰王海良文波郭致君庞加春丛日刚
Owner SHAOSHAN DABEINONG ANIMAL MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products